IPRIPR2018-00974Final Written Decision
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED et al.v.BioVie, Inc.
IPR challenge of US 9655945.
Type
IPR
Filed
Apr 27, 2018
Instituted
Nov 14, 2018
Decided
—
Patent
Application
15198050
Inventor
Paolo Angeli et al
Granted
May 23, 2017
01
Timeline
3 milestones
2018-04-27Petition filed
2018-11-14Institution
2019-11-13Terminated
02
Parties & counsel
Petitioner
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED et al.
Counsel
Murphy, Jameset al
Patent Owner
BioVie, Inc.
Counsel
Gattari, Patricket al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →